Articles tagged under: Mucormycosis

Zydus – TLC pact to market Liposomal Amphotericin B drug to treat Black Fungus or Mucormycosis

May 26, 2021
Zydus – TLC pact to market Liposomal Amphotericin B drug to treat Black Fungus or Mucormycosis

Ahmedabad (Press Statement): Zydus, an innovation driven global pharma major and TLC, a specialty pharmaceutical company in Taiwan, today announced the signing of a license supply and commercialization agreement to commercialize AmphoTLC™ (Amphotericin B Liposome for Injection 50mg) in India. AmphoTLC™ is a critical drug to treat Mucormycosis or Black Fungus in India. Under the terms of the agreement, TLC will manufacture and supply AmphoTLC™ on a non-exclusive basis to Zyd...Read More

Centre allocates more Amphotericin – B drug to States; Gujarat gets highest

May 26, 2021
Centre allocates more Amphotericin – B drug to States; Gujarat gets highest

New Delhi: Union Minister for Chemicals and Fertilizers Shri D.V Sadananda Gowda announced that the additional 29,250 vials of Amphotericin- B drug, used in treatment of Mucormycosis, have been allocated to all the States/UTs today. Gujarat has got highest 7,210 as the State has highest number of patients under treatment as on May 25. DeshGujarat Additional 29,250 vials of #Amphotericin- B drug, used in treatment of #Mucormycosis, have been allocated to all the States/UTs today.The allocation...Read More

Highest Mucormycosis cases in Gujarat; Centre sends 5800 vials today

May 22, 2021
Highest Mucormycosis cases in Gujarat; Centre sends 5800 vials today

New Delhi: The Central government has allocated 5800 vials of Amphotericin - B to Gujarat today against 2281 cases, the highest in the country, informed union minister Sadananda Gowda. Read More

Gujarat declares mucormycosis an epidemic

May 20, 2021
Gujarat declares mucormycosis an epidemic

Gandhinagar: Gujarat Chief Minister Vijay Rupani today said the State government has decided to declare mucormycosis disease as epidemic. This decision under the Epidemic Disease Act 1857 was taken in a core group meeting chaired by the Chief Minister. In this reference, now government and private hospitals and medical colleges will have to follow the guidelines declared by ICMR and Health department of the Government of India for screening, diagnosis and treatment of this disease which ...Read More

Centre asks States to publicise ‘Point of Contact’ for hospitals to obtain Amphotericin B

May 12, 2021
Centre asks States to publicise ‘Point of Contact’ for hospitals to obtain Amphotericin B

New Delhi: Ministry of Chemicals and Fertilizers in a note today said, 'after reviewing the stock position with the manufacturers/importers, and the demand pattern of Amphotericin B the Department of Pharma, has on 11th May, 2021 , allocated this drug amongst the States/UTs based on expected supply that will be available from May 10 to May 31, 2021. It said, 'a sudden increase in demand has been observed in some states for Amphotericin B which is being actively prescribed by the physicians to...Read More

Gujarat govt to buy 5,000 amphotericin B 50 MG injections to fight Mucormycosis

May 08, 2021
Gujarat govt to buy 5,000 amphotericin B 50 MG injections to fight Mucormycosis

Gandhinagar: The Government of Gujarat has decided to start separate wards to treat mucormycosis patients in civil hospitals of Ahmedabad, Vadoara, Surat, Rajkot, Bhavnagar and Jamnagar. The Government has also decided to order 5,000 amphotericin B 50 MG injections worth Rs. 3.12 crore for treatment of mucormycosis. The decisions were taken in a Core group meeting chaired by Chief Minister Vijay Rupani today evening in capital Gandhinagar. According to State government note, there have been 100 ...Read More